CRUZIVAX is a H2020 research project performing preclinical and clinical phase 1 studies of a needle-free vaccine it is developing against Trypanosoma cruzi. The vaccine will strengthen the pipeline of products for Chagas disease.
Read moreUploads must be directly related to the H2020 CRUZIVAX project funded under grant agreement no 815418.